A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. [electronic resource]
Producer: 20110531Description: 442-9 p. digitalISSN:- 1873-2402
- Adolescent
- Adult
- Cognition -- drug effects
- Cognition Disorders -- drug therapy
- Diagnostic and Statistical Manual of Mental Disorders
- Double-Blind Method
- Female
- GABA Agonists -- adverse effects
- Humans
- Male
- Middle Aged
- Neuropsychological Tests
- Psychiatric Status Rating Scales
- Pyridazines -- therapeutic use
- Receptors, GABA-A -- drug effects
- Schizophrenia -- drug therapy
- Schizophrenic Psychology
- Treatment Outcome
- Triazoles -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.